Results 271 to 280 of about 2,113,360 (356)
We identified adaptor protein ShcD as upregulated in triple‐negative breast cancer and found its expression to be correlated with reduced patient survival and increased invasion in cell models. Using a proteomic screen, we identified novel ShcD binding partners involved in EGFR signaling pathways.
Hayley R. Lau+11 more
wiley +1 more source
High-grade astrocytoma with piloid features: a single-institution case series and literature review. [PDF]
Goethe EA+5 more
europepmc +1 more source
Interplay of integrins and selectins in metastasis
Here we review the role of integrins and their interplay with selectins in metastasis. The efficacy of integrin‐targeted therapies may be reduced in tumors where metastasis relies heavily on selectins. In certain tumors, integrins and selectins exhibit a synergistic interaction during intraperitoneal dissemination.
Diana Maltseva+2 more
wiley +1 more source
Modified screening of MYC promotor region elements using the CRISPR library in ovarian cancer. [PDF]
Yamamoto A+7 more
europepmc +1 more source
Brian J. YOUNG, Promoters and Politicians. The North-Shore Railways in the History of Quebec, 1854-1885 [PDF]
Albert Faucher
openalex +1 more source
Inhibitor of DNA binding‐1 is a key regulator of cancer cell vasculogenic mimicry
Elevated expression of transcriptional regulator inhibitor of DNA binding 1 (ID1) promoted cancer cell‐mediated vasculogenic mimicry (VM) through regulation of pro‐angiogenic and pro‐cancerous genes (e.g. VE‐cadherin (CDH5), TIE2, MMP9, DKK1). Higher ID1 expression also increased metastases to the lung and the liver.
Emma J. Thompson+11 more
wiley +1 more source
Molecular cloning of gene sequences regulated by tumor promoters and mitogens through protein kinase C. [PDF]
Mark D. Johnson+3 more
openalex +1 more source